MP65-16 PREDICTOR FACTORS FOR SUCCESSFUL TREATMENT OF SOLIFENACIN IN PATIENTS WITH OVERACTIVE BLADDER

Factors associated with a better therapeutic effect of solifenacin in patients with overactive bladder syndrome.

AIMS To analyze the predictors of therapeutic success after solifenacin treatment. METHODS Between January 2008 and December 2011, all patients with overactive bladder syndrome (OAB) who consecutively visited the urologic outpatient clinics of a medical center were prospectively enrolled. All enrolled patients received 5 mg solifenacin once a day for 12 weeks. RESULTS Overall, 648 patients,...

Comparison of solifenacin and fesoterodine in treatment of overactive bladder

OBJECTIVE To compare the use of solifenacin and fesoterodine in treatment of overactive bladder (OAB). METHODS This prospective study was conducted on patients diagnosed with OAB who presenting to the Department of Obstetrics and Gynecology and Urology, School of Medicine, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey between October 2013 and August 2014. Patients were randomized...

Solifenacin: scientific evidence in the treatment of overactive bladder.

OBJECTIVES This article aims to analyse the use of solifenacin in the treatment of overactive bladder in order to show its efficacy and safety within the framework of the scientific evidence. METHODS The available scientific literature was reviewed, including most of the relevant clinical trials performed with solifenacin. RESULTS All the studies analysed show significant improvements in pa...

modern surgical techniques in treatment of patients with cleft lip & cleft palate

چکیده ندارد.

Solifenacin succinate (VESIcare): overactive bladder therapy.